Nrupen Bhavsar, PhD

Assistant Professor in Medicine
Assistant Professor in Biostatistics and Bioinformatics
Associate of the Duke Initiative for Science & Society
Campus mail 200 Morris St, 3rd Floor, Durham, NC 27710
Phone (919) 668-7211
Email address nrupen.bhavsar@duke.edu

I am a quantitative epidemiologist with methodological expertise in the design and analysis of observational studies that leverage data from cohort studies, registries, and the electronic health record (EHR). My background, training, and research is in the measurement and characterization of biomarkers, risk factors and treatment outcomes for chronic disease using real-world datasets. My primary research interests are in the use of novel sources of data, including the EHR, to conduct chronic disease research at the intersection of informatics, biostatistics, and epidemiology. My ongoing work aims to integrate informatics, epidemiology, and biostatistics to reduce the burden of chronic disease. I have topical expertise in multiple chronic diseases, including oncology, cardiovascular disease, and chronic kidney disease. In parallel, I have a portfolio of research that aims to understand the impact of social determinants of health, including dynamic neighborhood changes, such as gentrification, on the health of adults and children. 

Education and Training

  • Fellowship, Johns Hopkins University School of Medicine, 2011 - 2013
  • Fellowship, New York University School of Medicine, 2010 - 2011
  • Ph.D., Johns Hopkins University, 2010

Publications

Palta, Manisha, Priya Palta, Nrupen A. Bhavsar, Janet K. Horton, and Rachel C. Blitzblau. “The use of adjuvant radiotherapy in elderly patients with early-stage breast cancer: changes in practice patterns after publication of Cancer and Leukemia Group B 9343.” In Cancer, 121:188–93, 2015. https://doi.org/10.1002/cncr.28937.

PMID
25488523
Full Text

Bhavsar, Nrupen A., Jay H. Bream, Alan K. Meeker, Charles G. Drake, Sarah B. Peskoe, Djeneba Dabitao, Angelo M. De Marzo, William B. Isaacs, and Elizabeth A. Platz. “A peripheral circulating TH1 cytokine profile is inversely associated with prostate cancer risk in CLUE II.” Cancer Epidemiol Biomarkers Prev 23, no. 11 (November 2014): 2561–67. https://doi.org/10.1158/1055-9965.EPI-14-0010.

PMID
25150281
Full Text

Kamal, A., N. A. Bhavsar, S. Power, and P. J. Mosca. “Surgical interventions in cancer patients at the end of life: Experiences at an academic medical center.” J Clin Oncol 32, no. 30_suppl (October 20, 2014): 281. https://doi.org/10.1200/jco.2014.32.30_suppl.281.

PMID
28141243
Full Text

Bhavsar, N. A., M. R. Harrison, L. J. Howie, A. J. Armstrong, K. Davis, Q. Chen, M. R. Pupa, A. Abernethy, D. J. George, and B. R. Hirsch. “1072PEXPERIENCE OF PATIENTS TREATED WITH SIPULEUCEL-T IN AN ACADEMIC SETTING.” In Ann Oncol, 25:iv369–70, 2014. https://doi.org/10.1093/annonc/mdu342.25.

PMID
28171524
Full Text

Umbehr, Martin H., Elizabeth A. Platz, Sarah B. Peskoe, Nrupen A. Bhavsar, Jonathan I. Epstein, Patricia Landis, Alan W. Partin, and H Ballentine Carter. “Serum prostate-specific antigen (PSA) concentration is positively associated with rate of disease reclassification on subsequent active surveillance prostate biopsy in men with low PSA density.” Bju Int 113, no. 4 (April 2014): 561–67. https://doi.org/10.1111/bju.12131.

PMID
23746233
Full Text

Bhavsar, Nrupen A., Josef Coresh, and Brad C. Astor. “In Reply to 'Neutrophil Gelatinase-Associated Lipocalin (NGAL), Neutrophils, and CKD: Which Comes First?'.” Am J Kidney Dis 61, no. 1 (January 2013): 184. https://doi.org/10.1053/j.ajkd.2012.10.008.

PMID
23245740
Full Text

Pollack, Craig E., Elizabeth A. Platz, Nrupen A. Bhavsar, Gary Noronha, Gene E. Green, Sean Chen, and H Ballentine Carter. “Primary care providers' perspectives on discontinuing prostate cancer screening.” Cancer 118, no. 22 (November 15, 2012): 5518–24. https://doi.org/10.1002/cncr.27577.

PMID
22517310
Full Text

Bhavsar, Nrupen A., Anna Köttgen, Josef Coresh, and Brad C. Astor. “Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study.” Am J Kidney Dis 60, no. 2 (August 2012): 233–40. https://doi.org/10.1053/j.ajkd.2012.02.336.

PMID
22542304
Full Text

Pollack, Craig E., Gary Noronha, Gene E. Green, Nrupen A. Bhavsar, and H Ballentine Carter. “Primary care providers' response to the US Preventive Services Task Force draft recommendations on screening for prostate cancer.” Arch Intern Med 172, no. 8 (April 23, 2012): 668–70. https://doi.org/10.1001/archinternmed.2012.135.

PMID
22529237
Full Text

Bhavsar, Nrupen A., Lawrence J. Appel, John W. Kusek, Gabriel Contreras, George Bakris, Josef Coresh, Brad C. Astor, and Brad C. AASK Study Group. “Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD.” Am J Kidney Dis 58, no. 6 (December 2011): 886–93. https://doi.org/10.1053/j.ajkd.2011.07.018.

PMID
21944667
Full Text

Pages